We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTEV.WS
12276
DELISTED
FinTech Evolution Acquisition Group Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share
FTEV.WS
$22K ﹤0.01%
242,804
-214,278
-47% -$33.2K
LOTZ
12277
PUT
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$22K ﹤0.01%
55,500
-41,700
-43% -$30.9K
RYM
12278
PUT
RYTHM Inc
RYM
$45.3M
$21K ﹤0.01%
4
-6
-60% -$51K
YDKG
12279
Yueda Digital Holding
YDKG
$5.92M
$21K ﹤0.01%
+34
New +$18.9K
STEX
12280
PUT
Streamex Corp
STEX
$108M
$21K ﹤0.01%
3,230
-4,160
-56% -$39.1K
HUIZ
12281
Huize Holding Ltd
HUIZ
$12.5M
$21K ﹤0.01%
+3,425
New +$18.4K
LGHL
12282
CALL
Lion Group Holding
LGHL
$729K
0
MRIN
12283
PUT
DELISTED
Marin Software
MRIN
$21K ﹤0.01%
2,100
-11,850
-85% -$151K
NUVB.WS
12284
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$21K ﹤0.01%
73,715
+109
+0.1% +$70
REE
12285
PUT
DELISTED
REE Automotive
REE
$21K ﹤0.01%
603
-484
-45% -$24.8K
RIGL icon
12286
PUT
Rigel Pharmaceuticals
RIGL
$795M
$21K ﹤0.01%
1,830
+800
+78% +$16.1K
OLOX
12287
PUT
Olenox Industries
OLOX
$3.7M
$21K ﹤0.01%
2
-2
-50% -$23.3K
TMQ
12288
Trilogy Metals
TMQ
$646M
$21K ﹤0.01%
+27,666
New +$27.5K
UXIN
12289
PUT
Uxin Ltd
UXIN
$260M
$21K ﹤0.01%
502
-161
-24% -$9.64K
YGMZ
12290
DELISTED
MingZhu Logistics Holdings
YGMZ
$21K ﹤0.01%
+86
New +$19.5K
TECX
12291
CALL
Tectonic Therapeutic
TECX
$682M
$21K ﹤0.01%
1,933
-7,859
-80% -$92.6K
MKFG
12292
PUT
DELISTED
Markforged Holding Corporation
MKFG
$21K ﹤0.01%
1,120
+10
+0.9% +$292
GRTX
12293
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$21K ﹤0.01%
15,930
-122,654
-89% -$210K
TTOO
12294
CALL
DELISTED
T2 Biosystems, Inc
TTOO
$21K ﹤0.01%
26
-11
-30% -$16.3K
EGLX
12295
PUT
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$21K ﹤0.01%
10,300
-64,500
-86% -$140K
ARDS
12296
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$21K ﹤0.01%
19,481
-8,879
-31% -$11K
SPKBW
12297
DELISTED
Silver Spike Acquisition Corp II Warrant
SPKBW
$21K ﹤0.01%
347,000
-82,997
-19% -$13.8K
LHDX
12298
CALL
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$21K ﹤0.01%
11,300
-2,400
-18% -$5.83K
FCAX.WS
12299
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$21K ﹤0.01%
116,763
+1,001
+0.9% +$319
RCOR.WS
12300
DELISTED
Renovacor, Inc. Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11. 50 per whole share
RCOR.WS
$21K ﹤0.01%
301,227
-571
-0.2% -$83

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.